The Arcview Group

CBD: Cannabinoids Escape the Dispensary

Part of the Cannabis Intelligence Briefing series.

This report focused on the exploding CBD market reviews in-depth key factors in the CBD supply chain, from the differences in growing CBD hemp, industrial hemp and CBD-rich cannabis, to the coming battle for the consumer CBD dollar between dispensaries, pharmacies and general retail outlets.

Find out why CBD, the first cannabinoid to be distributed outside legal-state dispensaries, will not be the last…and what the implications of that will be.

Get a complete state-by-state rundown on the regulations surrounding hemp growing and CBD product distribution, as the states take the initiative just like they did with medical and adult-use cannabis legalization.

Purchase this report if you want to understand the nuances of the CBD market before you make substantive business decisions.

Share this page

Related Market Reports

Get the latest industry data to drive your decisions

The Arcview Group

The Arcview Group is a vertically integrated company servicing the cannabis and hemp industry, built with social justice and responsibility at its core. Arcview has been a trusted global leader for over ten years and nexus for investors, companies, entrepreneurs, and community, providing a broad spectrum of programs and services.

© 2024 The Arcview Group. All rights reserved.



Arcview Capital

Please be advised you are leaving the Arcview Group domain.